Synjardy 12.5 mg/1

Synjardy 12.5 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Synjardy 12.5 mg/1 tablets are used to help manage type 2 diabetes in adults. This combination medication works by improving blood sugar control, often used alongside diet and exercise. People may ask, 'What is Synjardy used for?' primarily to support glycemic management.

Common effects of Synjardy 12.5 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users experience mild dizziness or headache. Individual responses can vary, and not everyone will encounter these effects.

Handle Synjardy 12.5 mg/1 tablets with care, especially if you have kidney issues or are dehydrated. Always follow your healthcare provider's advice regarding usage. Store in a cool, dry place away from children.

Synjardy 12.5 mg/1 tablets may interact with certain medications, including diuretics and other diabetes treatments. Alcohol can also affect how this medication works. Discuss all current medications with your healthcare provider before starting Synjardy.